
Timothy Pluard
Saint Luke's Cancer Specialists · University of Missouri-Kansas City School of Medicine
Credentials: · · · · ·
History
- 1990–1992
Fellowship Dana-Farber Cancer Institute Harvard
- 1987–1990
Residency University of Texas Southwestern Med School

Research
Journal of Clinical Oncology · 2015 · 774 citations
Cell Reports · 2013 · 525 citations
Journal of Translational Medicine · 2018 · 425 citations
- CM
11 papers
- ME
11 papers
- MN
9 papers
- JS
6 papers
- EH
5 papers

5 papers
- JB
5 papers

5 papers
Clinical trials
- 2021–2023
Principal investigator · Unknown · Phase 2
Saint Luke's Health System
- 2011–2013
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
- 2025–2033
Site PI · Recruiting · Phase 3
Eli Lilly and Company
- 2025–2029
The Vanguard Study: Testing a New Way to Screen for Cancer
Site PI · Recruiting
National Cancer Institute (NCI)

